Versuchen GOLD - Frei
Trial By Fire
Express Pharma
|August 1-15, 2017
Born just a week after India gained independence, Indoco Remedies has witnessed and been a part of the trials and triumphs of the country's pharma sector for the last seven decades. Now, as we gear up to celebrate the 71st anniversary of the day which marked the end of colonial rule in India, the company has grown steadily to become a well-known entity in the Indian pharma sector.
Founded by late Govind Kare, Indoco Remedies was set up to import pharma formulations from Europe and distribute them in the Western India. However, the road ahead for the fledgling company in a newly liberated nation was no cake walk. Though it had a small pharma unit in Thane, Mumbai, most of Indoco's operations were handled out of Goa which was in the midst of its struggle for liberation. This made it very difficult for the company to manage its operations.
Goa's independence in 1961, ending Portuguese rule on the Gomantak heartland, proved to be a blessing to the company as well as it served to stabilise its operations. In 1963, when Suresh Kare, the founder's son took charge as the Managing Director, the company's annual turnover was around ₹ 3 lakhs and had 30 employees on payroll, a loss-making entity.
The turnaround
It was now up to the new leader to turn the company's fortunes and make it a profit-making venture. An uphill task in the business environment which existed in the country at that time. However, Suresh proved his mettle with hard work and business strategies that gradually put the company on the growth track. The government's decision to favour indigenous players over the MNCs who had dominated the industry since independence also spurred the growth trajectory of the company.
The passage of the Indian Patent Act in 1970, which brought in the regime of ‘Process Patents’, the export initiatives taken by the industry in 1990s, liberalisation of the economy in 1991, opened up new growth avenues for domestic players. Indoco, helmed by an able leader was able to capitalise on the opportunities and emerge as a significant entity in an expanding landscape.

Charting a success story
Diese Geschichte stammt aus der August 1-15, 2017-Ausgabe von Express Pharma.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Express Pharma
Express Pharma
Speed and flexibility play a critical role in how we compete with larger global players
Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma
6 mins
January 2026
Express Pharma
Vizag rising: Shaping India's pharma future
At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth
9 mins
January 2026
Express Pharma
Future of pharma: Trends, challenges & AI
Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies
2 mins
January 2026
Express Pharma
Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments
When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.
1 mins
January 2026
Express Pharma
Can Indian biosimilars and generics restate accessibility in global underserved markets?
Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare
3 mins
January 2026
Express Pharma
The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers
As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.
6 mins
January 2026
Express Pharma
Results win customers. Leadership discipline keeps them
Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.
3 mins
January 2026
Express Pharma
INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF
India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge
8 mins
January 2026
Express Pharma
PRUV® -The original Sodium Stearyl Fumarate
JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago
5 mins
January 2026
Express Pharma
Odisha's pharma pitch
The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury
5 mins
January 2026
Translate
Change font size
